57 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
ABT Abbott Laboratories $67.67 $118.71B Downtrend
Article Searches
CVS Health's (CVS) Q4 Earnings Top Estimates, Margins Up http://www.zacks.com/stock/news/355792/cvs-healths-cvs-q4-earnings-top-estimates-margins-up?cid=CS-ZC-FT-355792 Feb 20, 2019 - CVS Health's (CVS) recently introduced Health Care Benefits segment following the Aetna acquisition holds immense promise.
NuVasive (NUVA) Q4 Earnings Beat Estimates, Margins Fall http://www.zacks.com/stock/news/356399/nuvasive-nuva-q4-earnings-beat-estimates-margins-fall?cid=CS-ZC-FT-356399 Feb 22, 2019 - NuVasive (NUVA) reports growth in revenues across all key operating segments in the fourth quarter of 2018.
Here's Why Investors Should Hold DaVita (DVA) Stock Now http://www.zacks.com/stock/news/356474/heres-why-investors-should-hold-davita-dva-stock-now?cid=CS-ZC-FT-356474 Feb 22, 2019 - DaVita (DVA) steadily expands in international markets. Moreover, the company has witnessed Dialysis services in the United States lately.
Quest Diagnostics Grows on Innovation Amid Reimbursement Woe http://www.zacks.com/stock/news/356629/quest-diagnostics-grows-on-innovation-amid-reimbursement-woe?cid=CS-ZC-FT-356629 Feb 22, 2019 - Quest Diagnostics' (DGX) progress in prescription drug monitoring, QuantiFERON and non-invasive prenatal screening are part of its recent major developments.
Chemed (CHE) Q4 Earnings Beat Estimates, Gross Margin Falls http://www.zacks.com/stock/news/356727/chemed-che-q4-earnings-beat-estimates-gross-margin-falls?cid=CS-ZC-FT-356727 Feb 25, 2019 - Chemed's (CHE) Q4 revenues grow across key segments.
CVS Health Rides on Aetna Synergy, PBM Selling Season Modest http://www.zacks.com/stock/news/356736/cvs-health-rides-on-aetna-synergy-pbm-selling-season-modest?cid=CS-ZC-FT-356736 Feb 25, 2019 - With regard to its 2019 PBM selling season, CVS Health (CVS) notes that the net benefits from this selling season are expected to be modest on Anthem-related headwinds.
Here's Why Investors Should Buy DexCom (DXCM) Stock Now http://www.zacks.com/stock/news/357030/heres-why-investors-should-buy-dexcom-dxcm-stock-now?cid=CS-ZC-FT-357030 Feb 26, 2019 - Solid growth at the Sensor, Transmitter and Receiver segments provide DexCom (DXCM) a competitive edge in the MedTech space.
Bruker Rides on Robust NANO & CALID Groups, Recent Buyouts http://www.zacks.com/stock/news/357031/bruker-rides-on-robust-nano-calid-groups-recent-buyouts?cid=CS-ZC-FT-357031 Feb 26, 2019 - Bruker's (BRKR) CALID and NANO groups hold promise.
Here's Why You Should Buy Varian Medical (VAR) Stock Now http://www.zacks.com/stock/news/357351/heres-why-you-should-buy-varian-medical-var-stock-now?cid=CS-ZC-FT-357351 Mar 01, 2019 - Buoyed by a strong first quarter, Varian Medical (VAR) has kept its fiscal 2019 guidance intact.
Here's Why You Should Snap Up Abbott (ABT) Stock Right Now http://www.zacks.com/stock/news/357532/heres-why-you-should-snap-up-abbott-abt-stock-right-now?cid=CS-ZC-FT-357532 Mar 04, 2019 - Synergies from Alere consolidation in the form of revenues from Abbott's (ABT) Rapid Diagnostics business have been driving growth.

Pages: 123456

Page 1>